§ 48-853.07. Criteria for indicators of misuse; Director’s authority to disclose information; intervention.

(a) The Director may establish through rulemaking: (1) Criteria for indicators of misuse or abuse of covered substances; (2) A method for analysis of data collected by the Program using the criteria for indicators of misuse or abuse of covered substances; (3) Criteria for indications of a possible violation of law or a possible breach of professional standards by a prescriber or dispenser; and (4) A method for analysis of data collected by the Program using the criteria for indications of a possible violation of law or a possible breach of professional standards by a prescriber or dispenser. (b) (1) Upon the development of the criteria and data analysis, the Program may review prescription monitoring program data for indications of: (A) Possible misuse or abuse of a covered prescription drug; and (B) A possible violation of law or possible breach of professional standards by a prescriber or a dispenser. (2) If the Program's review of prescription monitoring data indicates a possible violation of paragraph (1) of this subsection, the Director may, in addition to any discretionary disclosure of information pursuant to this chapter : (A) Report the possible misuse or abuse by a patient to the specific prescriber or dispenser of the covered prescription drug for the purpose of intervention to prevent such misuse or abuse; (B) Notify the prescriber or dispenser of the possible violation of law or possible breach of professional standards; and (C) Provide education to the prescriber or dispenser.